{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T14:07:19Z","timestamp":1788876439139,"version":"build-2803163510"},"reference-count":123,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,19]],"date-time":"2026-04-19T00:00:00Z","timestamp":1776556800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004097","name":"ARC Foundation for Cancer Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004097","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Critical Reviews in Oncology\/Hematology"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.critrevonc.2026.105341","type":"journal-article","created":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T23:42:15Z","timestamp":1776728535000},"page":"105341","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Online adaptive radiotherapy: Clinical utility, challenges and perspectives"],"prefix":"10.1016","volume":"223","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6302-825X","authenticated-orcid":false,"given":"Morgan","family":"Michalet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeppe","family":"Friborg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan Richter","family":"Vogelius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Azria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.critrevonc.2026.105341_bib1","article-title":"Artificial intelligence potential impact on resident physician education in radiation oncology","volume":"9","author":"Almeida","year":"2024","journal-title":"Adv. Radiat. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105341_bib2","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s13014-020-01510-w","article-title":"1.5\u2009T MR-guided and daily adapted SBRT for prostate cancer: feasibility, preliminary clinical tolerability, quality of life and patient-reported outcomes during treatment","volume":"15","author":"Alongi","year":"2020","journal-title":"Radiat. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105341_bib3","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.radonc.2022.03.014","article-title":"Online adaptive radiotherapy of urinary bladder cancer with full re-optimization to the anatomy of the day: Initial experience and dosimetric benefits","volume":"171","author":"\u00c5str\u00f6m","year":"2022","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105341_bib4","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.radonc.2022.03.014","article-title":"Online adaptive radiotherapy of urinary bladder cancer with full re-optimization to the anatomy of the day: initial experience and dosimetric benefits","volume":"171","author":"\u00c5str\u00f6m","year":"2022","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105341_bib5","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.canrad.2024.06.002","article-title":"Radiation-induced lymphocyte apoptosis assay: Primetime for routine clinical use?","volume":"28","author":"Azria","year":"2024","journal-title":"Cancer\/Radio. \u00e9rapie"},{"key":"10.1016\/j.critrevonc.2026.105341_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2025.110981","article-title":"Cone-beam computed tomography-based online adaptive radiotherapy of esophageal cancer in the neoadjuvant setting: dosimetric analysis, toxicity and treatment response","volume":"209","author":"Bachmann","year":"2025","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105341_bib7","article-title":"Stereotactic body radiotherapy for hepatocellular carcinoma: meta-analysis and International Stereotactic Radiosurgery Society practice guidelines","volume":"0","author":"Bae","year":"2023","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.critrevonc.2026.105341_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.eururo.2025.02.020","article-title":"European association of urology guidelines on renal cell carcinoma: the 2025 update","author":"Bex","year":"2025","journal-title":"Eur. Urol."},{"key":"10.1016\/j.critrevonc.2026.105341_bib9","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1016\/j.ijrobp.2009.04.005","article-title":"Weekly volume and dosimetric changes during chemoradiotherapy with intensity-modulated radiation therapy for head and neck cancer: a prospective observational study","volume":"76","author":"Bhide","year":"2010","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.critrevonc.2026.105341_bib10","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s13014-024-02436-3","article-title":"Real world clinical experience using daily intelligence-assisted online adaptive radiotherapy for head and neck cancer","volume":"19","author":"Blumenfeld","year":"2024","journal-title":"Radiat. Oncol. Lond. Engl."},{"key":"10.1016\/j.critrevonc.2026.105341_bib11","first-page":"583","article-title":"Les pr\u00e9mices de la pratique avanc\u00e9e pour le manipulateur en radioth\u00e9rapie","volume":"27","author":"Boisbouvier","year":"2023","journal-title":"Cancer\/Radio. \u00e9rapie 34e Congr. \u00e8S. Natl. De. la Soci. \u00e9t\u00e9 fran\u00e7aise De. Radio. \u00e9rapie Oncol."},{"key":"10.1016\/j.critrevonc.2026.105341_bib12","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/s13014-024-02492-9","article-title":"MOREOVER: multiomics MR-guided radiotherapy optimization in locally advanced rectal cancer","volume":"19","author":"Boldrini","year":"2024","journal-title":"Radiat. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105341_bib13","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s13014-023-02271-y","article-title":"Magnetic resonance guided SBRT reirradiation in locally recurrent prostate cancer: a multicentric retrospective analysis","volume":"18","author":"Boldrini","year":"2023","journal-title":"Radiat. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105341_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2023.109912","article-title":"A prospective registry study of stereotactic magnetic resonance guided radiotherapy (MRgRT) for primary liver tumors","volume":"189","author":"Bordeau","year":"2023","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105341_bib15","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.3390\/jcm12031183","article-title":"Stereotactic MR-guided radiotherapy for liver metastases: first results of the montpellier prospective registry study","volume":"12","author":"Bordeau","year":"2023","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.critrevonc.2026.105341_bib16","doi-asserted-by":"crossref","first-page":"e43","DOI":"10.1002\/mp.12256","article-title":"Use of image registration and fusion algorithms and techniques in radiotherapy: report of the AAPM Radiation Therapy Committee Task Group No. 132","volume":"44","author":"Brock","year":"2017","journal-title":"Med. Phys."},{"key":"10.1016\/j.critrevonc.2026.105341_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2025.111087","article-title":"Magnetic resonance guided stereotactic reirradiation for locally recurrent prostate cancers: long-term results from a prospective registry study","volume":"211","author":"Buchalet","year":"2025","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105341_bib18","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.semradonc.2025.04.007","article-title":"Advancing prostate cancer treatment: a review of CT and MR-guided online adaptive radiotherapy techniques","volume":"35","author":"Casillas","year":"2025","journal-title":"Semin. Radiat. Oncol. Nov. Paradig. Adv. Prostate Cancer"},{"key":"10.1016\/j.critrevonc.2026.105341_bib19","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1001\/jamaoncol.2023.1352","article-title":"Weekly adaptive radiotherapy vs standard intensity-modulated radiotherapy for improving salivary function in patients with head and neck cancer: a phase 3 randomized clinical trial","volume":"9","author":"Castelli","year":"2023","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.critrevonc.2026.105341_bib20","doi-asserted-by":"crossref","DOI":"10.3389\/frai.2020.577620","article-title":"Integration of AI and machine learning in radiotherapy QA","volume":"3","author":"Chan","year":"2020","journal-title":"Front. Artif. Intell."},{"key":"10.1016\/j.critrevonc.2026.105341_bib21","doi-asserted-by":"crossref","first-page":"e486","DOI":"10.1016\/j.prro.2021.01.010","article-title":"Clinical implementation and initial experience of real-time motion tracking with jaws and multileaf collimator during helical tomotherapy delivery","volume":"11","author":"Chen","year":"2021","journal-title":"Pract. Radiat. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105341_bib22","article-title":"Clinical outcomes of patients with unresectable primary liver cancer treated with MR-guided stereotactic body radiation therapy: a six-year experience","volume":"41","author":"Chin","year":"2023","journal-title":"Clin. Transl. Radiat. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105341_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2023.110064","article-title":"Stereotactic MR-guided on-table adaptive radiation therapy (SMART) for borderline resectable and locally advanced pancreatic cancer: a multi-center, open-label phase 2 study","volume":"191","author":"Chuong","year":"2024","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105341_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.annonc.2023.08.009","article-title":"Pancreatic cancer: ESMO clinical practice guideline for diagnosis, treatment and follow-up5","volume":"34","author":"Conroy","year":"2023","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105341_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.clon.2024.08.005","article-title":"Artificial intelligence for radiation treatment planning: bridging gaps from retrospective promise to clinical reality","volume":"37","author":"Conroy","year":"2025","journal-title":"Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105341_bib26","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s13014-021-01791-9","article-title":"MR-guided stereotactic body radiation therapy for primary cardiac sarcomas","volume":"16","author":"Corradini","year":"2021","journal-title":"Radiat. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105341_bib27","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.858740","article-title":"1.5T MR-guided daily adaptive stereotactic body radiotherapy for prostate re-irradiation: a preliminary report of toxicity and clinical outcomes","volume":"12","author":"Cuccia","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105341_bib28","doi-asserted-by":"crossref","first-page":"72","DOI":"10.3390\/diagnostics11010072","article-title":"Delta radiomics analysis for local control prediction in pancreatic cancer patients treated using magnetic resonance guided radiotherapy","volume":"11","author":"Cusumano","year":"2021","journal-title":"Diagnostics"},{"key":"10.1016\/j.critrevonc.2026.105341_bib29","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.ijrobp.2025.03.049","article-title":"Feasibility of stereotactic body radiation therapy for pancreatic tumors abutting organs at risk using magnetic resonance guided adaptive radiation therapy","volume":"122","author":"D\u2019Souza","year":"2025","journal-title":"Int. J. Radiat. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105341_bib30","first-page":"172","article-title":"Radiotherapy for lung metastases: conventional to stereotactic body radiation therapy","volume":"33","author":"Das","year":"2023","journal-title":"Semin. Radiat. Oncol. Palliat. Care Radiat. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105341_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2024.110178","article-title":"silico evaluation and feasibility of near margin-less head and neck daily adaptive radiotherapy","volume":"197","author":"Dohopolski","year":"2024","journal-title":"Radiother. Oncol. J. Eur. Soc. Ther. Radiol. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105341_bib32","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.3390\/jpm12081245","article-title":"FMISO-based adaptive radiotherapy in head and neck cancer","volume":"12","author":"Dolezel","year":"2022","journal-title":"J. Pers. Med."},{"key":"10.1016\/j.critrevonc.2026.105341_bib33","doi-asserted-by":"crossref","first-page":"e353","DOI":"10.1016\/j.clgc.2022.03.011","article-title":"Cost effectiveness analysis of radiofrequency ablation (RFA) versus stereotactic body radiotherapy (SBRT) for early stage renal cell carcinoma (RCC)","volume":"20","author":"Donovan","year":"2022","journal-title":"Clin. Genitourin. Cancer"},{"key":"10.1016\/j.critrevonc.2026.105341_bib34","doi-asserted-by":"crossref","first-page":"6820","DOI":"10.3390\/curroncol30070499","article-title":"Radiotherapy for locally advanced pancreatic adenocarcinoma\u2014a critical review of randomised trials","volume":"30","author":"Ejlsmark","year":"2023","journal-title":"Curr. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105341_bib35","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1007\/s00066-024-02262-2","article-title":"Deep learning for autosegmentation for radiotherapy treatment planning: state-of-the-art and novel perspectives","volume":"201","author":"Erdur","year":"2025","journal-title":"Strahlenther. Onkol."},{"key":"10.1016\/j.critrevonc.2026.105341_bib36","doi-asserted-by":"crossref","DOI":"10.7759\/cureus.5774","article-title":"Real-time magnetic resonance-guided liver stereotactic body radiation therapy: an institutional report using a magnetic resonance-linac system","author":"Feldman","year":"2019","journal-title":"Cureus 11"},{"key":"10.1016\/j.critrevonc.2026.105341_bib37","doi-asserted-by":"crossref","first-page":"3266","DOI":"10.1200\/JCO-24-01502","article-title":"Benefit of chemoradiotherapy versus chemotherapy after induction therapy for conversion of unresectable into resectable pancreatic cancer: the randomized CONKO-007 trial","volume":"43","author":"Fietkau","year":"2025","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105341_bib38","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.ijrobp.2020.02.025","article-title":"Clinical outcomes of stereotactic MR-guided adaptive radiation therapy for high-risk lung tumors","volume":"107","author":"Finazzi","year":"2020","journal-title":"Int. J. Radiat. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105341_bib39","article-title":"Stereotactic ultrahypofractionated MR-guided radiotherapy for localized prostate cancer \u2013 Acute toxicity and patient-reported outcomes in the prospective, multicenter SMILE phase II trial","volume":"46","author":"Fink","year":"2024","journal-title":"Clin. Transl. Radiat. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105341_bib40","article-title":"Stereotactic body radiation therapy for liver metastases: systematic review and meta-analysis with international stereotactic radiosurgery society (ISRS) practice guidelines","volume":"0","author":"Franzese","year":"2024","journal-title":"Pract. Radiat. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105341_bib41","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1151256","article-title":"Outcome of the first 200 patients with prostate cancer treated with MRI-Linac at Assuta MC","volume":"13","author":"Gelbart Pridan","year":"2023","journal-title":"Front. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105341_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2023.109749","article-title":"Tumor volume changes during stereotactic ablative radiotherapy for adrenal gland metastases under MRI guidance","volume":"186","author":"Giraud","year":"2023","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105341_bib43","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.semradonc.2019.02.004","article-title":"Practical clinical workflows for online and offline adaptive radiation therapy","volume":"29","author":"Green","year":"2019","journal-title":"Semin. Radiat. Oncol. Adapt. Radiother. Autom."},{"key":"10.1016\/j.critrevonc.2026.105341_bib44","article-title":"Adaptive radiotherapy for oropharyngeal cancer with daily adapt-to-shape workflow on 1.5 T MRI-linac: preliminary outcomes and comparison with helical tomotherapy","volume":"53","author":"Guerini","year":"2025","journal-title":"Clin. Transl. Radiat. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105341_bib45","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s13014-022-01981-z","article-title":"MR-guided SBRT boost for patients with locally advanced or recurrent gynecological cancers ineligible for brachytherapy: feasibility and early clinical experience","volume":"17","author":"Hadi","year":"2022","journal-title":"Radiat. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105341_bib46","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0236570","article-title":"Initial clinical experience of Stereotactic Body Radiation Therapy (SBRT) for liver metastases, primary liver malignancy, and pancreatic cancer with 4D-MRI based online adaptation and real-time MRI monitoring using a 1.5 Tesla MR-Linac","volume":"15","author":"Hal","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.critrevonc.2026.105341_bib47","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1001\/jama.2016.4324","article-title":"Effect of chemoradiotherapy vs chemotherapy on survival in patients with locally advanced pancreatic cancer controlled after 4 months of gemcitabine with or without erlotinib: the LAP07 randomized clinical trial","volume":"315","author":"Hammel","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.critrevonc.2026.105341_bib48","article-title":"Ablative five-fraction stereotactic body radiation therapy for inoperable pancreatic cancer using online MR-guided adaptation","volume":"6","author":"Hassanzadeh","year":"2021","journal-title":"Adv. Radiat. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105341_bib49","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1016\/j.ijrobp.2006.11.014","article-title":"Increased risk of biochemical and clinical failure for prostate patients with a large rectum at radiotherapy planning: results from the Dutch trial of 68 GY versus 78 Gy","volume":"67","author":"Heemsbergen","year":"2007","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.critrevonc.2026.105341_bib50","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.radonc.2017.11.032","article-title":"Phase I trial of stereotactic MR-guided online adaptive radiation therapy (SMART) for the treatment of oligometastatic or unresectable primary malignancies of the abdomen","volume":"126","author":"Henke","year":"2018","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105341_bib51","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S1470-2045(24)00731-9","article-title":"Comparative efficacy and safety of ablative therapies in the management of primary localised renal cell carcinoma: a systematic review and meta-analysis","volume":"26","author":"Huang","year":"2025","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.critrevonc.2026.105341_bib52","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-22826-5","article-title":"MRI-based delta-radiomic features for prediction of local control in liver lesions treated with stereotactic body radiation therapy","volume":"12","author":"Jin","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.critrevonc.2026.105341_bib53","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.3390\/cancers17132061","article-title":"Ablative five-fraction CT versus MR-guided stereotactic body radiation therapy for pancreatic cancer: in silico evaluation of interfraction anatomic changes as a rationale for online adaptive replanning","volume":"17","author":"Kaiser","year":"2025","journal-title":"Cancers"},{"key":"10.1016\/j.critrevonc.2026.105341_bib54","doi-asserted-by":"crossref","first-page":"3554","DOI":"10.1002\/mp.14230","article-title":"Feasibility of real-time motion tracking using cine MRI during MR-guided radiation therapy for abdominal targets","volume":"47","author":"Keiper","year":"2020","journal-title":"Med. Phys."},{"key":"10.1016\/j.critrevonc.2026.105341_bib55","article-title":"Magnetic resonance imaging versus computed tomography guidance for stereotactic body radiotherapy in prostate cancer: 2-year outcomes from the MIRAGE randomized clinical trial","author":"Kishan","year":"2024","journal-title":"Eur. Urol."},{"key":"10.1016\/j.critrevonc.2026.105341_bib56","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1001\/jamaoncol.2022.6558","article-title":"Magnetic resonance imaging\u2013guided vs computed tomography\u2013guided stereotactic body radiotherapy for prostate cancer: the MIRAGE randomized clinical trial","volume":"9","author":"Kishan","year":"2023","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.critrevonc.2026.105341_bib57","doi-asserted-by":"crossref","first-page":"169","DOI":"10.3390\/tomography10010013","article-title":"Accelerated hypofractionated magnetic resonance guided adaptive radiation therapy for ultracentral lung tumors","volume":"10","author":"La Rosa","year":"2024","journal-title":"Tomography"},{"key":"10.1016\/j.critrevonc.2026.105341_bib58","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2025.110845","article-title":"Acute toxicity and quality of life after margin reduction using a sub-fractionation workflow for stereotactic radiotherapy of localized prostate cancer on a 1.5 Tesla MR-linac","volume":"207","author":"Lalmahomed","year":"2025","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105341_bib59","doi-asserted-by":"crossref","DOI":"10.1259\/bjro.20230030","article-title":"The role of artificial intelligence in radiotherapy clinical practice","volume":"5","author":"Landry","year":"2023","journal-title":"BJR|Open"},{"key":"10.1016\/j.critrevonc.2026.105341_bib60","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2023.110034","article-title":"Widening the therapeutic window for central and ultra-central thoracic oligometastatic disease with stereotactic MR-guided adaptive radiation therapy (SMART)","volume":"190","author":"Lee","year":"2024","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105341_bib61","article-title":"CT-guided online adaptive stereotactic body radiotherapy for pancreas ductal adenocarcinoma: dosimetric and initial clinical experience","volume":"48","author":"Lee","year":"2024","journal-title":"Clin. Transl. Radiat. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105341_bib62","doi-asserted-by":"crossref","DOI":"10.1002\/acm2.13930","article-title":"Evaluating motion of pancreatic tumors and anatomical surrogates using cine MRI in 0.35T MRgRT under free breathing conditions","volume":"24","author":"Lewis","year":"2023","journal-title":"J. Appl. Clin. Med. Phys."},{"key":"10.1016\/j.critrevonc.2026.105341_bib63","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/j.jtho.2021.03.019","article-title":"The HILUS-trial\u2014a prospective nordic multicenter phase 2 study of ultracentral lung tumors treated with stereotactic body radiotherapy","volume":"16","author":"Lindberg","year":"2021","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105341_bib64","article-title":"Clinical outcomes using magnetic resonance-guided stereotactic body radiation therapy in patients with locally advanced cholangiocarcinoma","volume":"5","author":"Luterstein","year":"2019","journal-title":"Adv. Radiat. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105341_bib65","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1038\/s41467-024-44824-z","article-title":"Segment anything in medical images","volume":"15","author":"Ma","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.critrevonc.2026.105341_bib66","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.1086258","article-title":"Dose accumulation for MR-guided adaptive radiotherapy: from practical considerations to state-of-the-art clinical implementation","volume":"12","author":"McDonald","year":"2023","journal-title":"Front. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105341_bib67","article-title":"Towards clinical implementation of T2-weighted cine imaging for intrafraction drift correction workflows on the 1.5 Tesla magnetic resonance-linear accelerator","volume":"36","author":"Meijers","year":"2025","journal-title":"Phys. Imaging Radiat. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105341_bib68","article-title":"Stereotactic body radiotherapy of central lung tumours using a 1.5 T MR-linac: First clinical experiences","volume":"45","author":"Merckel","year":"2024","journal-title":"Clin. Transl. Radiat. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105341_bib69","doi-asserted-by":"crossref","first-page":"291","DOI":"10.3390\/jcm12010291","article-title":"Stereotactic MR-guided radiotherapy for adrenal gland metastases: first clinical results","volume":"12","author":"Michalet","year":"2022","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.critrevonc.2026.105341_bib70","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.842402","article-title":"Stereotactic MR-guided radiotherapy for pancreatic tumors: dosimetric benefit of adaptation and first clinical results in a prospective registry study","volume":"12","author":"Michalet","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105341_bib71","doi-asserted-by":"crossref","unstructured":"Michalet, M., Riou, O., Cottet-Moine, J., Castan, F., Gourgou, S., Valdenaire, S., Debuire, P., Ailleres, N., Draghici, R., Charissoux, M., Moscardo, C.L., Farcy-Jacquet, M.-P., Fenoglietto, P., Azria, D., 2022c. Magnetic Resonance-Guided Reirradiation for Local Recurrence within the Prostate or in the Prostate Bed: One-Year Clinical Results of a Prospective Registry Study 14.","DOI":"10.3390\/cancers14081943"},{"key":"10.1016\/j.critrevonc.2026.105341_bib72","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijrobp.2025.03.039","article-title":"Development of multiparametric prognostic models for stereotactic magnetic resonance guided radiation therapy of pancreatic cancers","author":"Michalet","year":"2025","journal-title":"Int. J. Radiat. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105341_bib73","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S1470-2045(13)70021-4","article-title":"Gemcitabine-based or capecitabine-based chemoradiotherapy for locally advanced pancreatic cancer (SCALOP): a multicentre, randomised, phase 2 trial","volume":"14","author":"Mukherjee","year":"2013","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.critrevonc.2026.105341_bib74","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.semradonc.2014.02.008","article-title":"The viewray system: magnetic resonance\u2013guided and controlled radiotherapy","volume":"24","author":"Mutic","year":"2014","journal-title":"Semin. Radiat. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105341_bib75","doi-asserted-by":"crossref","DOI":"10.1002\/acm2.70245","article-title":"Feasibility of HyperSight CBCT for adaptive radiation therapy: a phantom benchmark study of dose calculation accuracy and delivery verification on the Halcyon","volume":"26","author":"Nelson","year":"2025","journal-title":"J. Appl. Clin. Med. Phys."},{"key":"10.1016\/j.critrevonc.2026.105341_bib76","doi-asserted-by":"crossref","unstructured":"Nicosia, L., Trapani, G., Rigo, M., Giaj-Levra, N., Mazzola, R., Pastorello, E., Ricchetti, F., Cuccia, F., Figlia, V., Fiorini, M., Alongi, F., 2022. 1.5 T MR-Guided Daily Adapted SBRT on Lymph Node Oligometastases from Prostate Cancer.","DOI":"10.20944\/preprints202210.0205.v1"},{"key":"10.1016\/j.critrevonc.2026.105341_bib77","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S1470-2045(10)70290-4","article-title":"Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial","volume":"12","author":"Nutting","year":"2011","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.critrevonc.2026.105341_bib78","first-page":"106","article-title":"The technical design and concept of a PET\/CT linac for biology-guided radiotherapy","volume":"29","author":"Oderinde","year":"2021","journal-title":"Clin. Transl. Radiat. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105341_bib79","doi-asserted-by":"crossref","first-page":"60","DOI":"10.3390\/curroncol32020060","article-title":"Evaluating CBCT-guided adaptive radiotherapy for pancreatic cancer using synthetic CBCT data","volume":"32","author":"Olberg","year":"2025","journal-title":"Curr. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105341_bib80","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1007\/s00066-016-1053-1","article-title":"Stereotactic body radiotherapy for renal cell cancer and pancreatic cancer: literature review and practice recommendations of the DEGRO Working Group on Stereotactic Radiotherapy","volume":"192","author":"Panje","year":"2016","journal-title":"Strahlenther. Onkol."},{"key":"10.1016\/j.critrevonc.2026.105341_bib81","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.3390\/curroncol31050203","article-title":"Online adaptive MR-guided ultrahypofractionated radiotherapy of prostate cancer on a 1.5 T MR-Linac: clinical experience and prospective evaluation","volume":"31","author":"Potkrajcic","year":"2024","journal-title":"Curr. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105341_bib82","doi-asserted-by":"crossref","DOI":"10.7759\/cureus.68386","article-title":"Transition of online adaptive stereotactic radiotherapy for pancreatic cancer from magnetic resonance-guided linear accelerator (MR-Linac) to state-of-the-art cone-beam computed tomography (CBCT)","author":"Rechner","year":"2024","journal-title":"Cureus 16 e68386"},{"key":"10.1016\/j.critrevonc.2026.105341_bib83","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.radonc.2022.01.038","article-title":"SMART ablation of lymphatic oligometastases in the pelvis and abdomen: clinical and dosimetry outcomes","volume":"168","author":"Regnery","year":"2022","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105341_bib84","doi-asserted-by":"crossref","DOI":"10.1016\/j.lungcan.2023.03.011","article-title":"To fly or not to fly: stereotactic MR-guided adaptive radiotherapy effectively treats ultracentral lung tumors with favorable long-term outcomes","volume":"179","author":"Regnery","year":"2023","journal-title":"Lung Cancer"},{"key":"10.1016\/j.critrevonc.2026.105341_bib85","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.3390\/cancers13071523","article-title":"Feasibility and early clinical experience of online adaptive MR-guided radiotherapy of liver tumors","volume":"13","author":"Rogowski","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.critrevonc.2026.105341_bib86","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.adro.2018.08.005","article-title":"A multi-institutional experience of MR-guided liver stereotactic body radiation therapy","volume":"4","author":"Rosenberg","year":"2019","journal-title":"Adv. Radiat. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105341_bib87","doi-asserted-by":"crossref","DOI":"10.1002\/cam4.2100","article-title":"Using adaptive magnetic resonance image-guided radiation therapy for treatment of inoperable pancreatic cancer","author":"Rudra","year":"2019","journal-title":"Cancer Med."},{"key":"10.1016\/j.critrevonc.2026.105341_bib88","article-title":"Magnetic resonance-guided stereotactic body radiation therapy\/hypofractionated radiation therapy for metastatic and primary central and ultracentral lung lesions","volume":"4","author":"Sandoval","year":"2023","journal-title":"JTO Clin. Res. Rep."},{"key":"10.1016\/j.critrevonc.2026.105341_bib89","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1186\/s13014-025-02722-8","article-title":"Adaptive radiotherapy for gastrointestinal malignancies","volume":"20","author":"Schiff","year":"2025","journal-title":"Radiat. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105341_bib90","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1186\/s13014-025-02730-8","article-title":"Advanced HyperSight\u2122 imaging for patients with adaptive SBRT of prostate cancer: a longitudinal analysis of tissue demarcation","volume":"20","author":"Schmidt","year":"2025","journal-title":"Radiat. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105341_bib91","doi-asserted-by":"crossref","DOI":"10.21037\/jtd.2018.04.52","article-title":"Stereotactic body radiation therapy (SBRT) for early stage nonsmall cell lung cancer (NSCLC): contemporary insights and advances","volume":"10","author":"Sebastian","year":"2018","journal-title":"J. Thorac. Dis."},{"key":"10.1016\/j.critrevonc.2026.105341_bib92","article-title":"Implementing cone-beam computed tomography-guided online adaptive radiotherapy in cervical cancer","volume":"40","author":"Shelley","year":"2023","journal-title":"Clin. Transl. Radiat. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105341_bib93","doi-asserted-by":"crossref","DOI":"10.1002\/jmrs.70020","article-title":"The Value of Radiation Therapists in Online Adaptive Radiotherapy","author":"Shepherd","year":"2025","journal-title":"J. Med. Radiat. Sci."},{"key":"10.1016\/j.critrevonc.2026.105341_bib94","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.1093\/jnci\/djaf232","article-title":"Impact of daily adaptive head and neck radiotherapy on toxicity and quality of life: results of the DARTBOARD phase II randomized trial","volume":"117","author":"Sher","year":"2025","journal-title":"JNCI J. Natl. Cancer Inst."},{"key":"10.1016\/j.critrevonc.2026.105341_bib95","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.phro.2020.12.004","article-title":"Clinical implementation of artificial intelligence-driven cone-beam computed tomography-guided online adaptive radiotherapy in the pelvic region","volume":"17","author":"Sibolt","year":"2021","journal-title":"Phys. Imaging Radiat. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105341_bib96","first-page":"202","article-title":"Dose calculation accuracy of a new high-performance ring-gantry CBCT imaging system for prostate and lung cancer patients","author":"Sijtsema","year":"2025","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105341_bib97","first-page":"623","article-title":"Artificial intelligence for quality assurance in radiotherapy","volume":"25","author":"Simon","year":"2021","journal-title":"Cancer\/Radio. \u00e9rapie 32e Congr. \u00e8S. Natl. De. la Soci. \u00e9t\u00e9 fran\u00e7aise De. Radio. \u00e9rapie Oncol."},{"key":"10.1016\/j.critrevonc.2026.105341_bib98","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1016\/S1470-2045(23)00513-2","article-title":"Stereotactic body radiotherapy for primary renal cell carcinoma: a systematic review and practice guideline from the International Society of Stereotactic Radiosurgery (ISRS)","volume":"25","author":"Siva","year":"2024","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.critrevonc.2026.105341_bib99","article-title":"MRI-guided radiotherapy in twenty fractions for localised prostate cancer; results from the MOMENTUM study","volume":"46","author":"Sritharan","year":"2024","journal-title":"Clin. Transl. Radiat. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105341_bib100","first-page":"643","article-title":"A review of the clinical evidence for intensity-modulated radiotherapy","volume":"22","author":"Staffurth","year":"2010","journal-title":"Clin. Oncol. Tech. Asp. Radiother."},{"key":"10.1016\/j.critrevonc.2026.105341_bib101","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1002\/cncr.32756","article-title":"Conventionally fractionated radiation therapy versus stereotactic body radiation therapy for locally advanced pancreatic cancer (CRiSP): an international systematic review and meta-analysis","volume":"126","author":"Tchelebi","year":"2020","journal-title":"Cancer"},{"key":"10.1016\/j.critrevonc.2026.105341_bib102","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.euo.2020.05.007","article-title":"Magnetic resonance-guided stereotactic radiotherapy for localized prostate cancer: final results on patient-reported outcomes of a prospective phase 2 study","volume":"4","author":"Tetar","year":"2021","journal-title":"Eur. Urol. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105341_bib103","first-page":"157","article-title":"Evaluation of CBCT based dose calculation in the thorax and pelvis using two generic algorithms","volume":"103","author":"Thing","year":"2022","journal-title":"Phys. Med. PM Int. J. Devoted Appl. Phys. Med. Biol. Off. J. Ital. Assoc. Biomed. Phys. AIFB"},{"key":"10.1016\/j.critrevonc.2026.105341_bib104","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.634507","article-title":"Technical challenges of real-time adaptive MR-guided radiotherapy","volume":"11","author":"Thorwarth","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105341_bib105","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1186\/s13014-021-01957-5","article-title":"Delta radiomics analysis of Magnetic Resonance guided radiotherapy imaging data can enable treatment response prediction in pancreatic cancer","volume":"16","author":"Tomaszewski","year":"2021","journal-title":"Radiat. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105341_bib106","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1016\/S1470-2045(22)00517-4","article-title":"Intensity-modulated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): 2-year toxicity results from an open-label, randomised, phase 3, non-inferiority trial","volume":"23","author":"Tree","year":"2022","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.critrevonc.2026.105341_bib107","doi-asserted-by":"crossref","DOI":"10.1016\/j.phro.2022.10.003","article-title":"Stereotactic ablative radiation for pancreatic cancer on a 1.5 Telsa magnetic resonance-linac system","author":"Tringale","year":"2022","journal-title":"Phys. Imaging Radiat. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105341_bib108","first-page":"565","article-title":"Delineation of target volume by radiation therapists during online adaptive radiation therapy: what authorization?","volume":"28","author":"Trouillet","year":"2024","journal-title":"Cancer\/Radio. \u00e9rapie 35e Congr. \u00e8S. De. la Soci. \u00e9t\u00e9 fran\u00e7aise De. Radio. \u00e9rapie Oncol."},{"key":"10.1016\/j.critrevonc.2026.105341_bib109","article-title":"Factors influencing local control after MR-guided stereotactic body radiotherapy (MRgSBRT) for adrenal metastases","author":"Ugurluer","year":"2024","journal-title":"Clin. Transl. Radiat. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105341_bib110","article-title":"MR-guided online adaptive stereotactic body radiotherapy (MRgSBRT) of primary lung tumors and lung oligometastases","author":"Ugurluer","year":"2024","journal-title":"Strahlenther. Onkol. Organ Dtsch. Rontgengesellschaft Al"},{"key":"10.1016\/j.critrevonc.2026.105341_bib111","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.radonc.2021.06.005","article-title":"Ablative radiotherapy for liver tumors using stereotactic MRI-guidance: a prospective phase I trial","volume":"170","author":"van Dams","year":"2022","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105341_bib112","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2025.110748","article-title":"1-year efficacy results after MR-guided risk-adapted stereotactic radiotherapy of infra-diaphragmatic oligometastases in a multicenter phase II trial","volume":"205","author":"van Overeem Felter","year":"2025","journal-title":"Radiother. Oncol. J. Eur. Soc. Ther. Radiol. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105341_bib113","doi-asserted-by":"crossref","unstructured":"Vera, P., Thureau, S., Berriolo-Riedinger, A., Pourel, N., Broglia, J.M., Boissellier, P., Guillemard, S., Salem, N., Brenot-Rossi, I., P\u00e9choux, C.L., Berthold, C., Giroux-Leprieur, E., Moreau, D., Guillerm, S., Benali, K., Tessonnier, L., Audigier-Valette, C., Lerouge, D., Quak, E., Massabeau, C., Courbon, F., Moisson, P., Larrouy, A., Modzelewski, R., Gouel, P., Ghazzar, N., Langlais, A., Amour, E., Zalcman, G., Giraud, P., 2024. Adaptive radiotherapy (up to 74 Gy) or standard radiotherapy (66 Gy) for patients with stage III non-small- cell lung cancer, according to [18F]FDG-PET tumour residual uptake at 42 Gy (RTEP7\u2013IFCT-1402): a multicentre, randomised, controlled phase 2 trial 25.","DOI":"10.1016\/S1470-2045(24)00320-6"},{"key":"10.1016\/j.critrevonc.2026.105341_bib114","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/S1470-2045(24)00103-7","article-title":"Towards world-class radiotherapy in the UK: time for transformation","volume":"25","author":"Wakeham","year":"2024","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.critrevonc.2026.105341_bib115","doi-asserted-by":"crossref","DOI":"10.1148\/ryai.230024","article-title":"TotalSegmentator: Robust Segmentation of 104 Anatomic Structures in CT Images","volume":"5","author":"Wasserthal","year":"2023","journal-title":"Radiol. Artif. Intell."},{"key":"10.1016\/j.critrevonc.2026.105341_bib116","article-title":"Patient-reported outcomes following magnetic resonance-guided radiation therapy for prostate cancer: a systematic review and meta-analysis","volume":"120","author":"Westerhoff","year":"2024"},{"key":"10.1016\/j.critrevonc.2026.105341_bib117","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1007\/s00066-021-01834-w","article-title":"Stereotactic body radiotherapy of lymph node metastases under MR-guidance: first clinical results and patient-reported outcomes","volume":"198","author":"Weykamp","year":"2022","journal-title":"Strahlenther. Onkol."},{"key":"10.1016\/j.critrevonc.2026.105341_bib118","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.3389\/fonc.2021.610637","article-title":"Magnetic resonance-guided stereotactic body radiotherapy of liver tumors: initial clinical experience and patient-reported outcomes","volume":"11","author":"Weykamp","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105341_bib119","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1053\/j.semtcvs.2024.10.005","article-title":"Systematic Review of Stereotactic Ablative Radiotherapy (SABR)\/Stereotactic Body Radiation Therapy (SBRT) for Treatment of High-Risk Patients with Stage I Non-Small Cell Lung Cancer","volume":"37","author":"Wolf","year":"2025","journal-title":"Semin. Thorac. Cardiovasc. Surg."},{"key":"10.1016\/j.critrevonc.2026.105341_bib120","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.jmir.2020.11.013","article-title":"Perceptions of Canadian radiation oncologists, radiation physicists, radiation therapists and radiation trainees about the impact of artificial intelligence in radiation oncology \u2013 national survey","volume":"52","author":"Wong","year":"2021","journal-title":"J. Med. Imaging Radiat. Sci."},{"key":"10.1016\/j.critrevonc.2026.105341_bib121","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1088\/0031-9155\/42\/1\/008","article-title":"Adaptive radiation therapy","volume":"42","author":"Yan","year":"1997","journal-title":"Phys. Med. Biol."},{"key":"10.1016\/j.critrevonc.2026.105341_bib122","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.euo.2023.07.002","article-title":"Stereotactic magnetic resonance\u2013guided adaptive radiation therapy for localized kidney cancer: early outcomes from a prospective phase 1 trial and supplemental cohort","volume":"7","author":"Yim","year":"2024","journal-title":"Eur. Urol. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105341_bib123","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/j.ijrobp.2025.01.018","article-title":"Safety and efficacy of unresectable malignant cardiac tumors treated with concurrent chemoradiation therapy using a 1.5T MR-linac (GASTO-1078)","volume":"122","author":"Zheng","year":"2025","journal-title":"Int. J. Radiat. Oncol."}],"container-title":["Critical Reviews in Oncology\/Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842826002283?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842826002283?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T07:02:34Z","timestamp":1780038154000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1040842826002283"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":123,"alternative-id":["S1040842826002283"],"URL":"https:\/\/doi.org\/10.1016\/j.critrevonc.2026.105341","relation":{},"ISSN":["1040-8428"],"issn-type":[{"value":"1040-8428","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Online adaptive radiotherapy: Clinical utility, challenges and perspectives","name":"articletitle","label":"Article Title"},{"value":"Critical Reviews in Oncology\/Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.critrevonc.2026.105341","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"105341"}}